Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
22
10
2019
medline:
19
12
2020
entrez:
22
10
2019
Statut:
ppublish
Résumé
Animal models suggest that early markers of Sjögren syndrome (EMS)-antibodies against salivary protein 1, parotid secretory protein, and carbonic anhydrase 6 (CA6)-are more accurate signals of early Sjögren when compared with classic markers (anti-Ro and anti-La). To further understand the relationship between EMS and dry eye (DE), we compared symptoms and signs of DE in subjects who tested positive versus negative for EMS. In this cross-sectional study, patients at the Miami Veterans Affairs Eye Clinic who were tested for EMS underwent a standard ocular surface examination. Indications for EMS testing included DE symptoms in combination with dry mouth symptoms, low tear production, corneal staining, or a Sjögren disease-associated autoimmune disease. Statistical tests performed were the χ test, Fisher exact test, independent sample t test, and Spearman correlation. Seventy-three percent of 44 patients tested positive for 1 or more EMS. CA6 IgG was most frequently elevated, followed by CA6 IgM and parotid secretory protein IgG. EMS-positive versus EMS-negative subjects were more likely to escalate DE treatment past artificial tears to topical cyclosporine (n = 32, 100% vs. n = 9, 75%, P = 0.02). There were no demographic or comorbidity differences between EMS-positive and EMS-negative subjects, and marker levels did not correlate with more severe tear film measures. Most of the individuals with DE tested positive for 1 or more EMS antibodies, including men and Hispanics. Future studies will be needed to understand how to incorporate EMS data into the care of an individual with DE.
Identifiants
pubmed: 31634227
doi: 10.1097/ICO.0000000000002171
pmc: PMC7007845
mid: NIHMS1538674
pii: 00003226-202003000-00007
doi:
Substances chimiques
Antibodies, Antinuclear
0
BPIFA2 protein, human
0
Biomarkers
0
Ribonucleoproteins
0
SS-A antigen
0
SS-B antibodies
0
Salivary Proteins and Peptides
0
Carbonic Anhydrases
EC 4.2.1.1
carbonic anhydrase VI
EC 4.2.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-315Subventions
Organisme : BLRD VA
ID : I01 BX004893
Pays : United States
Organisme : CSRD VA
ID : I01 CX001089
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY014801
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026174
Pays : United States
Références
BMC Ophthalmol. 2015 Apr 10;15:38
pubmed: 25881294
Arthritis Care Res (Hoboken). 2019 Jul;71(7):949-960
pubmed: 30044541
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
Arthritis Rheum. 2009 May 15;61(5):711-4
pubmed: 19405009
Cont Lens Anterior Eye. 2010 Apr;33(2):55-60
pubmed: 20093066
J Immunol. 2013 Jul 15;191(2):608-13
pubmed: 23772034
Clin Immunol. 2018 Mar;188:58-63
pubmed: 29292085
Cornea. 2018 Nov;37(11):1425-1430
pubmed: 30161055
Am J Ophthalmol. 2015 Sep;160(3):447-452.e1
pubmed: 26093285
Ocul Surf. 2017 Jul;15(3):539-574
pubmed: 28736342
Am Fam Physician. 2009 Mar 15;79(6):465-70
pubmed: 19323359
Am J Physiol. 1997 Apr;272(4 Pt 1):G863-71
pubmed: 9142919
Open Rheumatol J. 2017 Jan 31;11:10-15
pubmed: 28400867
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
J Histochem Cytochem. 2002 Jun;50(6):821-7
pubmed: 12019298
Clin Exp Immunol. 2007 May;148(2):281-7
pubmed: 17286756
J Immunol Res. 2019 Jan 13;2019:7935451
pubmed: 30766890
Clin Immunol. 2014 Nov;155(1):42-46
pubmed: 25178982
Clin Immunol. 2012 Dec;145(3):251-5
pubmed: 23123440
BMC Ophthalmol. 2017 Mar 7;17(1):20
pubmed: 28270126
Biol Sex Differ. 2017 May 12;8:16
pubmed: 28507729
BMJ. 1998 Apr 18;316(7139):1236-8
pubmed: 9553006
J Histochem Cytochem. 1990 Jul;38(7):941-7
pubmed: 2113069
Biochem Genet. 1989 Oct;27(9-10):613-37
pubmed: 2482730
Arthritis Care Res (Hoboken). 2014 Mar;66(3):454-63
pubmed: 23983119
Ann Rheum Dis. 2014 May;73(5):861-70
pubmed: 23572339
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
J Med Case Rep. 2014 May 11;8:145
pubmed: 24885364
Invest Ophthalmol Vis Sci. 2015 May;56(5):2867-71
pubmed: 26024073
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Clin Immunol. 2009 Mar;130(3):304-12
pubmed: 19038581
Subcell Biochem. 2014;75:9-30
pubmed: 24146372
Am J Ophthalmol Case Rep. 2017 Oct 06;8:48-52
pubmed: 29260117
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
Clin Rheumatol. 2008 Dec;27(12):1479-83
pubmed: 18553114
Clin Ophthalmol. 2016 Jul 20;10:1329-34
pubmed: 27499612